Friday, August 07, 2020 12:25:24 PM
https://www.fool.com/investing/2020/08/05/teladoc-health-merging-with-livongo-health-in-deal.aspx
The largest U.S. telemedicine provider will acquire the leading applied health signals company for a combination of cash and stock.
Cory Renauer
(TMFang4apples)Aug 5, 2020 at 10:14AM
The virtual care field got a little smaller on Wednesday morning. Teladoc Health (NYSE:TDOC) will acquire Livongo Health (NASDAQ:LVGO) for a combination of cash and stock that adds up to $18.5 billion based on Teladoc's closing price on Tuesday.
Under the terms of the deal, which has been approved by both company's boards, investors will receive 0.592 shares of Teladoc Health plus $11.33 in cash for each share of Livongo they hold. Once the acquisition is complete, Livongo's former shareholders will hold around 42% of the new company's total shares outstanding.
Last week, Teladoc Health reported that its second-quarter revenue had leaped by 85% year over year to $241 million; Livongo's revenues have been rising even faster. Along with news of the merger, Livongo reported second-quarter earnings Wednesday morning that beat expectations on the top and bottom lines.
In Q2, Livongo's total revenue soared 125% year over year to $91.9 million, which was $5.2 million more than analysts' consensus expectation. It also reported adjusted earnings of $0.11 per share, which was $0.10 per share more than the consensus estimate.
The combined new virtual care Goliath is expected to report $1.3 billion in total revenue this year, with adjusted earnings of $120 million.
Livongo's diabetes service sends timely, personalized health feedback to over 410,000 members that helps them manage their condition more effectively. After the acquisition, this figure will most likely swell, along with the usage of its more recently launched services for weight management and hypertension, given that many of the tens of millions of people in the U.S. with healthcare plans that include access to Teladoc Health are managing chronic conditions.
Recent HLYK News
- HealthLynked Announces Fourth Quarter and Full Year 2023 Results Highlighted by 70% Reduction in Net Loss for Q4 • InvestorsHub NewsWire • 04/02/2024 12:00:00 PM
- HealthLynked Announces Exciting New Update with HealthLynked 3.2.0 - Transforming Patient-Care Through Innovation • InvestorsHub NewsWire • 03/26/2024 12:00:00 PM
- HealthLynked Corp Announces Chris Hall as New Chief Technology Officer • InvestorsHub NewsWire • 03/19/2024 12:00:00 PM
- HealthLynked Welcomes David Rosal as New Chief Financial Officer • InvestorsHub NewsWire • 03/13/2024 12:00:00 PM
- HealthLynked Welcomes Garrett Gardi to Its Advisory Board • InvestorsHub NewsWire • 02/28/2024 01:00:00 PM
- HealthLynked and CEO Dr. Michael Dent Featured in Health Documentary "Forever: The End of Aging," Now Available for Streaming • InvestorsHub NewsWire • 01/24/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 08:57:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:05:14 PM
- HealthLynked Unveils Advanced Search Functionality to Improve Patient Care • InvestorsHub NewsWire • 12/13/2023 01:00:00 PM
- HealthLynked Announces Q3 & Year-to-Date 2023 Financial Results, Highlighted by 8% Revenue Growth and Net Income Turnaround • InvestorsHub NewsWire • 11/15/2023 01:00:00 PM
- Introducing the New HealthLynked COVID-19 Tracker: A Comprehensive Tool for the Modern Pandemic Era • InvestorsHub NewsWire • 10/12/2023 12:00:00 PM
- HealthLynked Receives Medicare Shared Savings Net Proceeds from Sale of ACO Health Partners • InvestorsHub NewsWire • 10/09/2023 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2023 08:05:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2023 08:05:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2023 08:05:28 PM
- HealthLynked Announces Patent Filing for ARI: A Revolutionary AI-Powered Healthcare Interface • InvestorsHub NewsWire • 10/03/2023 12:00:00 PM
- HealthLynked Achieves Key Milestone with Final $300,000 Payment from Sale of ACO Health Partners • InvestorsHub NewsWire • 09/05/2023 12:00:00 PM
- HealthLynked Announces Steady YoY Revenue Increase for Q2 & H1 2023, Highlighting Significant Net Income Boost • InvestorsHub NewsWire • 08/15/2023 12:21:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:12:45 PM
- HealthLynked Corp. Names Wall Street Veteran Mike Paisan to Strategic Investor Relations Role • InvestorsHub NewsWire • 08/01/2023 12:00:00 PM
- HealthLynked Provides Financial Update • InvestorsHub NewsWire • 06/21/2023 12:00:00 PM
- HealthLynked Unveils Major App Update, Enhancing Personalized Healthcare Experience • InvestorsHub NewsWire • 06/06/2023 12:00:00 PM
- HealthLynked Corp. Announces Appointment of Bill Crupi as Regional Manager of Healthcare Services • InvestorsHub NewsWire • 05/23/2023 12:00:00 PM
- Solid Revenue Growth and Earnings Define HealthLynked's Q1 2023 • InvestorsHub NewsWire • 05/16/2023 12:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM